A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
- Status
- UNKNOWN
- Phase
- N/A
The Pharmacological Effects of Using Cabozantinib With a Light Breakfast
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Biomarkers of Response to Systemic Treatments in FH-deficient RCC
- Status
- UNKNOWN
- Phase
- N/A
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617
- Status
- UNKNOWN
- Phase
- NA
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
- Status
- RECRUITING
- Phase
- PHASE3
Circulating Tumor Cell Reducing No-touch Nephrectomy
- Status
- COMPLETED
- Phase
- NA
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Status
- RECRUITING
- Phase
- N/A
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2